March 10, 2022 by Chain Drug Review
CVS Health, David Dorman, Karen Lynch, Roger Farah, Tony White
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health Corp. announced Thursday that David Dorman, independent chair of the board of directors of CVS Health, will retire at the end of his current term, effective with the annual meeting of stockholders to be held on May 11. In addition, the board has unanimously selected Roger Farah to succeed Dorman
November 6, 2020 by Chain Drug Review
CVS Health, David Dorman, Karen Lynch, Larry Merlo
Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health’s board of directors announced on Friday that Larry Merlo, who has served as CEO of CVS Health for a decade, is stepping down from his role next year and Karen Lynch, currently executive vice president, CVS Health and president, Aetna, will become the company’s next president and chief executive officer,
February 3, 2020 by Chain Drug Review
CVS, CVS board of directors, CVS Health, David Dorman, Richard "Dick" Swift, Richard Bracken and Mark Bertolini
Leading Headlines, Pharmacy, Retail News, Uncategorized
WOONSOCKET, R.I. — CVS Health has announced upcoming changes to its board of directors. Richard “Dick” Swift, Richard Bracken and Mark Bertolini will not stand for reelection at the company’s 2020 Annual Meeting. The board will then be reduced from 16 to 13 directors in order to further align with corporate governance best practices. Swift, the former
June 5, 2017 by Mark Baumgartner and Chain Drug Review
CVS board of directors, CVS Health, CVS Health annual shareholders meeting, David Dorman, Mary Schapiro
2017, Issue 06-05-2017, Issues, News
WOONSOCKET, R.I. — Mary Schapiro, former chair of the Securities and Exchange Commission, has been elected to the board of directors at CVS Health. Schapiro joins the 11 directors re-elected during the CVS Health annual shareholders meeting last month. “We welcome Mary’s extraordinary record of leadership and unmatched commitment to investor protection and sound financial
May 10, 2017 by Chain Drug Review
CVS Health, CVS Health board, CVS Health's annual shareholders meeting, David Dorman, Mary Schapiro, SEC chairman
Business, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health shareholders re-elected all 11 members of the company’s board and voted to elect Mary Schapiro, former chairman of the Securities and Exchange Commission (SEC), as a new director. The elections took place Wednesday at CVS Health’s annual shareholders meeting at the company headquarters in Woonsocket, R.I. Directors re-elected to the